https://www.rush.edu/clinical-trials/septal-occluder-and-antiplatelet-medical-management-reduction-recurrent-stroke
Study to evaluate closing the patent foramen ovale (PFO) [a small opening in the heart] by using a medical device called the GORE CARDIOFORM Septal Occluder in...
medical managementseptalantiplateletreductionrecurrent
https://www.mdpi.com/2379-139X/7/4/66
The aim was to assess the occurrence of magnetic susceptibility artifacts (MSA) following endovascular treatment of intracranial aneurysm by stent using...
the combinationstentantiplatelettherapymay
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.1065350/full
Context: Tumor-associated cutaneous vascular disorder induced by PPGL was extremely rare, and the cutaneous manifestations could disappear after removal of t...
case reportfrontiersantiplatelettherapymetastatic
https://pubmed.ncbi.nlm.nih.gov/29126112/
Our registry data suggest that using appropriate risk scoring to guide antiplatelet therapy after ACS is safe and can result in improved clinical outcomes.
riskscoringguideantiplatelettherapy